JAMIE BRENNAN: Open Payments
NPI 1689031536 · HIGHLAND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 68 payments from 20 companies in 2025. Trend: 2023 $1,377 · 2024 $1,377 · 2025 $1,297
Food & beverage: $1,252Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $183 |
| ABBVIE INC. | 10 | $171 |
| Novo Nordisk Inc | 6 | $125 |
| Exact Sciences Corporation | 4 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $90 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| Abbott Laboratories | 3 | $58 |
Products named: MOUNJARO, Kerendia, UBRELVY, REXULTI, TRELEGY ELLIPTA, VOQUEZNA, XIFAXAN, VRAYLAR.
Industry payments across IN — which companies pay providers there.
